Seguir
S.E.M. Veldhuijzen van Zanten
S.E.M. Veldhuijzen van Zanten
MD/PhD/Assistant Professor
Dirección de correo verificada de erasmusmc.nl
Título
Citado por
Citado por
Año
Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International …
LM Hoffman, SEM Veldhuijzen van Zanten, N Colditz, J Baugh, B Chaney, ...
Journal of clinical oncology 36 (19), 1963-1972, 2018
3222018
Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria
MH Jansen, SE Veldhuijzen van Zanten, E Sanchez Aliaga, ...
Neuro-oncology 17 (1), 160-166, 2015
1712015
Molecular drug imaging: 89Zr-bevacizumab PET in children with diffuse intrinsic pontine glioma
MH Jansen, SEMV van Zanten, DG Van Vuurden, MC Huisman, DJ Vugts, ...
Journal of Nuclear Medicine 58 (5), 711-716, 2017
842017
Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease
SEM Veldhuijzen van Zanten, J Baugh, B Chaney, D De Jongh, ...
Journal of neuro-oncology 132, 255-266, 2017
612017
Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
FE El-Khouly, SEM Veldhuijzen van Zanten, V Santa-Maria Lopez, ...
Journal of neuro-oncology 145, 177-184, 2019
572019
A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands
SEM Veldhuijzen van Zanten, MHA Jansen, E Sanchez Aliaga, ...
Expert review of anticancer therapy 15 (2), 157-164, 2015
522015
A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo
DS Ziegler, J Keating, S Kesari, EM Fast, L Zawel, N Ramakrishna, ...
Neuro-oncology 13 (8), 820-829, 2011
432011
Effective drug delivery in diffuse intrinsic pontine glioma: a theoretical model to identify potential candidates
FE El-Khouly, DG Van Vuurden, T Stroink, E Hulleman, GJL Kaspers, ...
Frontiers in oncology 7, 254, 2017
382017
A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma
SEM Veldhuijzen van Zanten, FE El-Khouly, MHA Jansen, DP Bakker, ...
Journal of Neuro-oncology 135, 307-315, 2017
372017
The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease
J Baugh, U Bartels, J Leach, B Jones, B Chaney, KE Warren, J Kirkendall, ...
Journal of neuro-oncology 132 (2), 323-331, 2017
342017
External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry
SEM Veldhuijzen van Zanten, A Lane, MW Heymans, J Baugh, B Chaney, ...
Journal of neuro-oncology 134, 231-240, 2017
322017
Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey
SEMV van Zanten, CLLI van Meerwijk, MHA Jansen, JWR Twisk, ...
Neuro-oncology 18 (4), 582, 2016
312016
A suggestion to introduce the diagnosis of “diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)”
AO von Bueren, M Karremann, GH Gielen, M Benesch, M Fouladi, ...
Acta Neuropathologica 136, 171-173, 2018
292018
Multiregional tumor drug-uptake imaging by PET and microvascular morphology in end-stage diffuse intrinsic pontine glioma
SEMV van Zanten, ACP Sewing, A van Lingen, OS Hoekstra, P Wesseling, ...
Journal of Nuclear Medicine 59 (4), 612-615, 2018
272018
State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature
SEM Veldhuijzen van Zanten, O Cruz, GJL Kaspers, DR Hargrave, ...
Journal of Neuro-oncology 128, 387-394, 2016
272016
The added value of diagnostic and theranostic PET imaging for the treatment of CNS tumors
IJ Pruis, GAMS van Dongen, SEM Veldhuijzen van Zanten
International journal of molecular sciences 21 (3), 1029, 2020
252020
Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma
M Bugiani, SEMV van Zanten, V Caretti, P Schellen, E Aronica, DP Noske, ...
Oncotarget 8 (36), 60447, 2017
232017
A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma
FE El-Khouly, SEM Veldhuijzen van Zanten, MHA Jansen, DP Bakker, ...
Journal of Neuro-oncology 153 (2), 263-271, 2021
212021
FAPI PET versus FDG PET, CT or MRI for staging pancreatic-, gastric-and cholangiocarcinoma: systematic review and head-to-head comparisons of diagnostic performances
SEM Veldhuijzen van Zanten, KJ Pieterman, BPL Wijnhoven, IJ Pruis, ...
Diagnostics 12 (8), 1958, 2022
192022
Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parameters
IJ Pruis, SR Koene, SR Van Der Voort, F Incekara, AJPE Vincent, ...
Neuro-oncology advances 4 (1), vdac023, 2022
122022
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20